Ausgewählte Publikationen

Metzeler KH, Herold T, Rothenberg-Thurley M, Amler S, Sauerland MC, Goerlich D, Schneider S, Konstandin NP, Dufour A, Bräundl K, Ksienzyk B, Zellmeier E, Hartmann L, Greif PA, Fiegl M, Subklewe M, Bohlander SK, Krug U, Faldum A, Berdel WE, Wörmann B, Büchner T, Hiddemann W, Braess J, Spiekermann K (2016)

Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia.

Blood doi: blood-2016-01-693879. [Epub ahead of print]


Vick B, Rothenberg M, Sandhöfer N, Carlet M, Finkenzeller C, Krupka C, Grunert M, Trumpp A, Corbacioglu S, Ebinger M, André MC, Hiddemann W, Schneider S, Subklewe M, Metzeler KH, Spiekermann K, Jeremias I (2015)

An advanced preclinical mouse model for acute myeloid leukemia using patients' cells of various genetic subgroups and in vivo bioluminescence imaging.

PLoS One 10 (3): e0120925


Metzeler KH, Maharry K, Kohlschmidt J, Volinia S, Mrózek K, Becker H, Nicolet D, Whitman SP, Mendler J, Schwind S, Eisfeld AK, Wu Y-Z, Powell BL, Carter TH, Wetzler M, Kolitz JE, Baer MR, Carroll AJ, Stone RM, Caligiuri MA, Marcucci G, Bloomfield CD (2013)

A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia.

Leukemia 27 (10): 2023-3.


Metzeler KH, Maharry K, Radmacher MD, Mrózek K, Margeson D, Becker H, Curfman J, Holland KB, Schwind S, Whitman SP, Wu Y-Z, Blum W, Powell BL, Carter TH, Wetzler M, Moore JO, Kolitz JE, Baer MR, Carroll AJ, Larson RA, Caligiuri MA, Marcucci G, Bloomfield CD (2011)

TET2 mutations improve the new European LeukemiaNet (ELN) risk classification of acute myeloid leukemia: A Cancer and Leukemia Group B study.

J Clin Oncol 29 (10): 1373-1381.


Metzeler KH, Hummel M, Bloomfield CD, Spiekermann K, Sauerland MC, Heinecke A, Radmacher M, Marcucci G, Whitman SP, Maharry K, Paschka P, Larson RA, Berdel WE, Büchner T, Wörmann B, Mansmann U, Hiddemann W, Bohlander SK, Buske C (2008)

An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia.

Blood 112 (10): 4193-4201.


Alle in PubMed gelisteten Publikationen dieses Autors